2022 Feb 7. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–.
PMID:31643211
Sofosbuvir.
[No authors listed]
2022 Feb 7. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–.
PMID:31644130
Zepatier.
[No authors listed]
2022 Feb 7. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–.
PMID:31644238
Biomarkers in Detection of Hepatitis C Virus Infection.
Drug-induced liver injury by glecaprevir/pibrentasvir treatment for chronic hepatitis C infection: a systematic review and meta-analysis.
Hung HY, Hung WL, Shih CL, Chen CY.
Ann Med. 2022 Dec;54(1):108-120. doi: 10.1080/07853890.2021.2012589.
PMID:34969349
Late presentation of chronic viral hepatitis for medical care: a consensus definition.
Mauss S, Pol S, Buti M, Duffell E, Gore C, Lazarus JV, der Grient HL, Lundgren J, Mozalevskis A, Raben D, Schatz E, Wiktor S, Rockstroh JK; European consensus working group on late presentation for Viral Hepatitis Care.
BMC Med. 2017 May 3;15(1):92. doi: 10.1186/s12916-017-0856-y.
PMID:28464883
Treatment of Chronic Hepatitis C Virus Using Direct Acting Antivirals in Geriatric Egyptian Patients.
Elkadeem M, Shoman SR.
Recent Adv Antiinfect Drug Discov. 2021;16(2):157-165. doi: 10.2174/2772434416666210716123909.
PMID:34961434
Hepatitis C virus antibodies in acute icteric and chronic non-A, non-B hepatitis.
McHutchison JG, Kuo G, Houghton M, Choo QL, Redeker AG.